CryoFuture Secures Liss Capital Investment After Clinic Growth

CryoFuture announced a strategic partnership with Liss Capital Partners on January 13, 2026, as the fertility specimen storage company accelerates expansion following a series of clinic partnerships and facilities opening over the past year.

The investment follows CryoFuture's strategic partnerships with at least five fertility clinics in late 2024 and early 2025, including Mid Iowa Fertility, which transitioned all long-term specimens to CryoFuture’s Addison, Illinois, facility on January 7, 2025. Other clinic partners include IVFMD Texas, Boca Fertility, Viera Fertility, and Fertility and Surgical Associates of California.

The San Mateo-based company opened facilities in Chicago and Dallas in January 2025, expanding its network to seven locations across the US, including the Bay Area, Los Angeles, San Diego, Dallas, Chicago, Atlanta, and New York/New Jersey, with expansions to Seattle, Denver, South Florida, and Boston, though specific timelines were not provided.

Founded by senior embryologist Sean Pae and healthcare executive Cherie Kloss, CryoFuture provides long-term specimen storage, cryotransportation, and proprietary inventory management and billing solutions to IVF clinics and patients. The company has developed proprietary inventory management software that integrates with existing clinic systems, along with a digital portal for patient account management.

Strategic Position and Technology

CryoFuture describes itself as the largest network of fertility-dedicated biorepositories in the United States. The company competes with established players, including ReproTech, which operates five facilities and claims 35 years of experience with 800+ partner fertility centers, and TMRW Life Sciences, which operates facilities in Boulder, CO, and New York and uses automated specimen management technology.

Benefits Platform Distribution

CryoFuture has secured distribution agreements with major fertility benefits platforms. The company serves as an in-network specimen transportation provider for Progyny, a publicly traded fertility benefits provider (NASDAQ: PGNY) that reported 600+ employer clients and 7.6 million covered lives. Progyny reported $324 million in revenue for the first quarter of 2025.

The company has also partnered with Sunfish, an IVF financing platform that allows patients to include CryoFuture storage costs in their fertility loans.

The Outsourcing Trend

This pattern of clinic partnerships suggests a growing adoption of outsourcing long-term storage among fertility clinics. Some clinics describe the approach as a “widely recognized best practice.” However, the extent of professional organization endorsement is unclear.

​​Mid Iowa Fertility stated the partnership allows the practice to "focus on maximizing care for current and future patients" rather than managing long-term storage operations, signaling a strategic shift toward outsourcing non-core functions.

The Liss Capital partnership positions CryoFuture to accelerate this model as fertility clinics face operational decisions around long-term storage infrastructure. Whether the pace of clinic partnerships and benefits platform agreements continues as it has in 2024–2025 depends on how quickly this outsourcing model gains traction in the fertility care industry.

Financial terms of the Liss Capital partnership were not disclosed. The Chicago-based investment firm focuses on partnering with founder-and family-owned businesses in the lower middle market and was represented by Lippes Mathias LLP in the transaction.

"We are proud to partner with a category leader and look forward to helping accelerate CryoFuture's continued expansion as clinics and patients increasingly seek safer, more transparent, and more reliable solutions," said Cameron Liss, co-managing partner of Liss Capital Partners.